Cognition Therapeutics, Inc. (CGTX) Reports In-Line Q2 EPS

Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q2 EPS of ($0.11), in-line with the analyst estimate of ($0.11).

For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.

You May Also Be Interested In

• Citi reiterates buy rating on Advanced Energy Industries
• Fox Factory Holding (FOXF) Reiterated at Buy by Stifel on Reduced Leverage Post Marucci Sale
• Quantum Cyber files audited financials for $4.18M Arcade acquisition